Category Archives: Healthcare

Global Laboratory Equipment Market Research Report (2018-2023)

Laboratory

Aarkstore Market Research Enterprise entitles the new approach into a Market Research Report “Global Laboratory Equipment Market (2018-2023)

The global laboratory equipment market is projected to expand at a compound annual growth rate (CAGR) of 8.0% during the 2018-2023 period, and will reach USD 84.4 Bn by 2023. Increasing life sciences research is responsible for a major part of the huge demand for laboratory equipment across the globe. The market is segmented based on technologies like spectroscopy, chromatography, flow cytometry, next-generation sequencing, etc. Increase in incidence of chronic diseases such as diabetes and respiratory ailments, and the higher demand for timely and early detection of diseases will aid the growth of the market in the near future.

Segmentation based on technologies

Based on technologies, the ‘other’ technologies segment had the highest market share (45.8%) in 2018, owing to a growing geriatric population, rapidly emerging diagnostics centers and hospitals, and technological advancements. Time-consuming operations and mechanical failure of equipment are major challenges faced by users. It is followed by the spectroscopy segment, with a market share of 21.3% in 2018. This is due to the increased demand for spectrometers in the life sciences sector for the analysis of drugs and biomolecules.

Regional insights

The North America laboratory equipment market is projected to expand at a CAGR of 7.8% during the 2018-2023 period, leading to global revenue of USD 33.7 Bn by 2023. An increasing number of clinical trials and higher funding for life sciences research will aid the growth of the market. Europe, a region characterized by high awareness and a wide range of laboratory equipment, is anticipated to expand at a CAGR of 7.9% during the forecast period. The Asia-Pacific laboratory equipment market is expected to expand at the highest CAGR (8.4%) during the 2018-2023 period. Latin America, and the Middle East and Africa markets, still in the nascent stages, will also experience high growth.

Companies covered
• Danaher Corporation
• Thermo Fischer
• Agilent Technologies
• Waters Corporation
• PerkinElmer Corporation
• Bio-Rad Laboratories
• Shimadzu Corporation
• Bruker Corporation

Related Reports:

Contact Details:

Aarkstore Enterprise
Phone: +91 – 22 2756 4963
24/7 Online Support: +91 9987295242
Email: enquiry@aarkstore.com
Our website: https://www.aarkstore.com
Our blog: https://www.aarkstore.com/blog
Follow us on LinkedIn – https://www.linkedin.com/company/aarkstore-enterprise/

Advertisements

Bio Pharmaceutical India Market Research Report

Bio-Pharmaceuticals Market

Aarkstore Market Research Enterprise entitles the new approach into a Market Research Report “Bio-Pharmaceuticals Market In India

Bio-pharmaceutical products are manufactured in the form of complex macromolecules developed through genetic manipulation of living organisms using gene cloning, recombination of DNA and cell fusion. The biotechnology industry comprises bio-pharmaceuticals, bio-agriculture, bio-informatics, bio-services, and bio-industry.

Bio-pharmaceuticals Industry in India (2018-2023)

Market insights:
The bio-pharmaceuticals market in India is expected to reach a value of INR 2,891.70 Bn in FY 2023, expanding at a compound annual growth rate (CAGR) of ~31.7% since FY 2018. India caters to nearly 50% of the global demand for pharmaceutical products, most of which are based on the usage of biotechnological applications. Currently, bio-pharmaceuticals is one of the fastest growing biotechnology segments in India. The significant bio-pharmaceutical clusters of India are located in Haridwar, Sikkim, Hyderabad, Vishakhapatnam, Chennai, Pondicherry, Mysore, Mumbai, Ahmedabad, and Delhi NCR.

Government initiatives and investments:
The major investors in the Indian bio-pharmaceutical market are AstraZeneca, Johnson & Johnson, GlaxoSmithKline (GSK), Nipro and Otsuka. In 2017, 46 mergers and acquisition (M&A) deals were signed in the Indian bio-pharmaceutical market, generating business worth INR 94.77 Bn. The Indian government has taken the initiative to set up an electronic platform for regulating online pharmacies. ‘Pharma Vision 2020’ has been unveiled so that India can emerge as a global leader in terms of end-to-end drug manufacturing.

Key growth drivers of the market:
India comprises of ~0.13 Mn highly skilled and experienced scientists who serve as a strong support system for the business process of the bio-pharmaceutical industry. With the help of the educational qualifications and skillset of these people, India is considered to be a significant center for bio-pharmaceutical research and development (R&D), especially for vaccine manufacturing.
The Government of India has approved an investment of INR 15,000 Mn under the Innovate in India (i3) program, for collaboration of industrial organizations and academic organizations over the next five years. This program is considered to act as a significant action of the Government in its way of boosting bio-pharmaceutical production in the country.

Key deterrents to the growth of the market:

It often takes a long time for the manufacturing companies to launch a new market-ready bio-pharmaceutical product in India due to the existence of numerous regulatory challenges in the process.
Also, the Indian bio-pharmaceutical industry lacks proper infrastructure regarding limited government-sponsored laboratory space, consumables, chemical components, and equipment, which acts as a significant hindrance to the growth of the market.

Companies covered:
Biocon Ltd.
Cadila Healthcare Ltd.
Dr. Reddy’s Laboratories Ltd.
Panacea Biotec Ltd.
Wockhardt Ltd.
GSK Pharmaceuticals Ltd.
Bharat Biotech International Ltd.
Bharat Serums and Vaccines Ltd.
Indian Immunologicals Ltd.
Serum Institute of India Pvt. Ltd.


Related Reports:

Contact Details:

Aarkstore Enterprise
Phone: +91 – 22 2756 4963
24/7 Online Support: +91 9987295242
Email: enquiry@aarkstore.com
Our website: https://www.aarkstore.com
Our blog: https://www.aarkstore.com/blog
Follow us on LinkedIn – https://www.linkedin.com/company/aarkstore-enterprise/

Global Mouthguard Market Status And Forecast Analysis 2016-2025

Mouthguard Market.jpg

Aarkstore Market Research culminates the newest Market Research Report “Global Mouthguard Market Status And Forecast Analysis 2016-2025

This report studies the Mouthguard market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Mouthguard market by product type and applications/end industries.

The global Mouthguard market is valued at XX million USD in 2018 and is expected to reach XX million USD by the end of 2025.

The major players in global Mouthguard market includes:

ShockDoctor
ATI
Decathlon
Nike
Opro Mouthguards
Mueller
Venum
Battle Sports Science
Maxxmma
Fight Dentist
Mogo Sport

Major regions in global Mouthguard market includes:

Asia-Pacific
North America
Europe
South America
Middle East & Africa

Major types in global Mouthguard market includes:

Preformed Mouthguard
Thermoformed Mouthguard
Custom Mouthguard

Major application in global Mouthguard market includes:

Sport Enthusiasts
Player
Medical
For more inquiry contact our sales team at contact@aarkstore.com

Related Reports:

Contact Details:

Aarkstore Enterprise
Phone: +91 – 22 2756 4963
24/7 Online Support: +91 9987295242
Email: enquiry@aarkstore.com
Our website: https://www.aarkstore.com
Our blog: https://www.aarkstore.com/blog
Follow us on LinkedIn – https://www.linkedin.com/company/aarkstore-enterprise/

 

Global Laboratory Equipment Services Market 2025

The global laboratory equipment market is projected to expand at a compound annual growth rate (CAGR) of 8.0% during the 2018-2023 period and will reach USD 84.4 Bn by 2023. Increasing life sciences research is responsible for a major part of the huge demand for laboratory equipment across the globe. The market is segmented based on technologies like spectroscopy, chromatography, flow cytometry, next-generation sequencing, etc. Increase in the incidence of chronic diseases such as diabetes and respiratory ailments, and the higher demand for timely and early detection of diseases will aid the growth of the market in the near future.

Global Laboratory Equipment Market

Segmentation based on technologies

Based on technologies, the ‘other’ technologies segment had the highest market share (45.8%) in 2018, owing to a growing geriatric population, rapidly emerging diagnostics centers and hospitals, and technological advancements. Time-consuming operations and mechanical failure of equipment are major challenges faced by users. It is followed by the spectroscopy segment, with a market share of 21.3% in 2018. This is due to the increased demand for spectrometers in the life sciences sector for the analysis of drugs and biomolecules.

Regional insights

The North America laboratory equipment market is projected to expand at a CAGR of 7.8% during the 2018-2023 period, leading to global revenue of USD 33.7 Bn by 2023. An increasing number of clinical trials and higher funding for life sciences research will aid the growth of the market. Europe, a region characterized by high awareness and a wide range of laboratory equipment, is anticipated to expand at a CAGR of 7.9% during the forecast period. The Asia-Pacific laboratory equipment market is expected to expand at the highest CAGR (8.4%) during the 2018-2023 period. Latin America, and the Middle East and Africa markets, still in the nascent stages, will also experience high growth.

Companies covered

  • Danaher Corporation
  • Thermo Fischer
  • Agilent Technologies
  • Waters Corporation
  • PerkinElmer Corporation
  • Bio-Rad Laboratories
  • Shimadzu Corporation
  • Bruker Corporation

Category:  Healthcare Market Research Reports

Contact Details:

Aarkstore Enterprise

Phone: +91 998 729 5242 | contact@aarkstore.com

Dental consumables show marginal share growth.

Dental consumables are the devices consist of dental sundries used in dental clinics that assist in the treatment of patients. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market.

Global Dental Consumables Market 2023

Dental Consumables Report by Material, Application, and Geography-Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe, and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea, and China).

In this report, the global Dental Consumables market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2023, growing at a CAGR of XX% during the period 2019 to 2023.

The report firstly introduced the Dental Consumables basics: definitions, classifications, applications, and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand, and market growth rate and forecast, etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:

3M ESPE

Dentsply Sirona

Danaher

GC Corporation

Ivoclar Vivadent

Shofu

Mitsui Chemicals (Heraeus Kulzer)

VOCO GmbH

Ultradent

Coltene

DMG

The end users/applications and product categories analysis:

On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-

Amalgam

Composite Materials

Glass Ionomers

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Dental Consumables for each application, including-

Hospital

Dental Clinic

Category:  Healthcare Market Research Reports

Contact Details:

Aarkstore Enterprise

Phone: +91 998 729 5242 | contact@aarkstore.com

Healthcare Providers in Singapore

Summary

Healthcare Providers in Singapore industry profile provides top-line qualitative and quantitative Summary information including market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

HEALTHCARE PROVIDERS IN SINGAPORE 2024.jpg

Key Highlights

– The healthcare providers sector is valued as total expenditure on healthcare in each country. This includes final consumption spending on healthcare goods and services.

– The Singaporean healthcare providers sector had total revenues of $15.8bn in 2018, representing a compound annual growth rate (CAGR) of 8.7% between 2014 and 2018.

– The performance of the sector is forecast to decelerate, with an anticipated CAGR of 4.9% for the five-year period 2018-2023, which is expected to drive the sector to a value of $20.1bn by the end of 2023.

– Healthcare expenditure in Singapore has grown mainly through government funding, while healthcare costs have been inflated.

Scope

– Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the healthcare providers market in Singapore

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the healthcare providers market in Singapore

– Leading company profiles reveal details of key healthcare providers market players’ global operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the Singapore healthcare providers market with five-year forecasts

Reasons to buy

– What was the size of the Singapore healthcare providers market by value in 2018?

– What will be the size of the Singapore healthcare providers market in 2023?

– What factors are affecting the strength of competition in the Singapore healthcare providers market?

– How has the market performed over the last five years?

– What are the main segments that makeup Singapore’s healthcare providers market?

Category:  Healthcare Market Research Reports

Contact Details:

Aarkstore Enterprise

Phone: +91 998 729 5242 | contact@aarkstore.com

Chinese medical device and healthcare market-an analysis.

Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global LNG Carrier Containment Market. The Global LNG Carrier Containment market has been analyzed by Carrier Type (Moss Type, Membrane Type), By Propulsion Type (Steam Reheat, ME-GI, DFDE, SSD Steam, TFDE, XDF, Others), By Capacity (30,000-124,999cm, 125,000-149,999cm, 150,000-180,000cm, >180,000cm). The Global LNG Carrier Containment market has been analyzed by Region (Americas, Europe, APAC, ROW) and by Country (United States, Bermuda, Greece, Norway, United Kingdom, China, Japan, Malaysia, South Korea, Qatar) for the historical period of 2014-2018 and the forecast period of 2019-2024.

LATEST CHINESE GUIDEBOOK FOR MEDICAL DEVICE 2019

China is one of the fastest growing global economies with a one-fifth population in the world. Nowadays, China has become the world’s second largest healthcare market after the United States. Along with sustained economic and population growth, and rapid population aging, the Chinese healthcare market has maintained an annual compound growth rate above 16 % since the 2010s. The statistical data showed that the scale of the Chinese healthcare market has reached RMB 6464.1 billion (about equivalent to US$973.5 billion) by 2017. Among them, the total value of medical device sales was RMB 663.2 billion (US$95.2 billion) with the annual compound growth rate of 20.27% by 2017. Medical devices have been widely used in the process of disease prevention, diagnosis, therapy, care, and rehabilitation.

However, large and medium-sized medical devices, high-end medical equipment and high-value medical materials are mainly relying on imported, such as the high-tech and high-valued imaging systems and navigation and positioning systems. Facing a gigantic population and rapid population aging, the Chinese government, on one side, accelerated the priority approval of innovative medical devices and relaxed the market access for overseas medical devices, on another side, intensified the supervision and administration for medical devices at the post—marketed. In recent years, China’s fast-track approval time is much shorter than any other country, which attracts more and more overseas medical device manufacturers to enter the Chinese healthcare market. Undoubtedly the Chinese healthcare market of nearly 1.4 billion populations is the huge business opportunities for the overseas medical device manufacturers.

At the same time, the Chinese regulatory authorities are changing regulatory framework to intensify the supervision and administration. The Chinese “State Administration for Market Regulation” and the “National Health Commission” jointly issued the latest version of “Measures for Medical Device Adverse Event Monitoring and Re-evaluation” in August 2018, which has been implemented on January 1, 2019. This is a challenge to overseas medical device manufacturers. To capture the huge business opportunities of the Chinese healthcare market and seize a larger part of the Chinese healthcare market, how do the foreign medical device manufacturers in compliance with the latest Chinese regulations on medical devices? How do the overseas medical device manufacturers operate business smoothly in China? Most importantly, overseas and multinational medical device manufacturers should always stand ready to respond to further regulation and policy changes occurred in China.

The overseas and multinational medical device manufacturers and their senior executive officers engaging in regulatory affairs need a thorough knowledge of the Chinese regulations for medical device adverse event reporting, monitoring and re-evaluation. China’s regulatory approach and culture are unique.

Latest Chinese Guidebook for Medical Device Adverse Events Reporting, Monitoring and Re-Evaluation (2019 Edition) is an essential resource for overseas and multinational medical device manufacturers to handle the medical device adverse event reporting, monitoring and re-evaluation smoothly in China, which provided a detailed guidance of comprehensive and thorough knowledge of the Chinese medical device adverse event reporting, monitoring and re-evaluation regulations.

Reasons to Buy

The Chinese “State Administration for Market Regulation” and the “National Health Commission” jointly issued the latest version of “Measures for Medical Device Adverse Event Monitoring and Re-evaluation” in August 2018, which has been implemented on January 1, 2019.

This is a challenge for overseas medical device manufacturers. To capture the huge business opportunities of the Chinese healthcare market and seize a larger part of the Chinese healthcare market, how do the foreign medical device manufacturers in compliance with the latest Chinese regulations on medical devices? How do the overseas medical device manufacturers operate business smoothly in China? Most importantly, overseas and multinational medical device manufacturers should always stand ready to respond to further regulation and policy changes occurred in China. The overseas and multinational medical device manufacturers and their senior executive officers engaging in regulatory affairs need a thorough knowledge of the Chinese regulations for medical device adverse event reporting, monitoring and re-evaluation. China’s regulatory approach and culture are unique.

Latest Chinese Guidebook for Medical Device Adverse Events Reporting, Monitoring and Re-Evaluation (2019 Edition) is an essential resource for overseas and multinational medical device manufacturers to handle the medical device adverse event reporting, monitoring and re-evaluation smoothly in China, which provided a detailed guidance of comprehensive and thorough knowledge of the Chinese medical device adverse event reporting, monitoring and re-evaluation regulations.

 Report Highlights

A brief description for China’s healthcare market landscape and rapidly changing regulatory framework that let the overseas and multinational medical device manufacturers clearly understand the present-day realities of the Chinese healthcare market landscape and rapidly changing regulatory framework, and tell the overseas and multinational medical device manufacturers the opportunities and challenges.

The Chinese regulatory authorities at various administrative levels and their respective functions and the Chinese huge medical device adverse event monitoring information network.

The detailed Chinese regulations for the marketing authorization holders’ duties and obligations that are important for the overseas and multinational medical device manufacturers and the agents within the territory of China designated by the overseas medical device manufacturers, because they must fulfill these duties and obligations that are stipulated by the Chinese regulatory authorities.

The detailed Chinese regulations for the medical device distributors’ and medical device user facilities’ duties and obligations that are important for the distributors within the territory of China designated by the overseas and multinational manufacturers exporting medical device products to China, because they must also fulfill their duties and obligations that are stipulated by the Chinese regulatory authorities.

The detailed Chinese regulations for the medical device adverse event reporting and evaluation, from the basic requirements, the different types of medical device adverse event reporting, and the time limitations for different types of medical device adverse event reporting to an entire process of medical device adverse event reporting to smoothly navigate complex regulatory requirements step by step, which is important for the overseas and multinational manufacturers of imported medical devices and the agents within the territory of China designated by the overseas medical device manufacturers, because they must be in compliance with these regulations.

The detailed description of how Chinese regulatory authorities implement the key monitoring on certain medical devices.

The detailed guidelines for the marketing authorization holders of the overseas and multinational medical device manufacturers exporting medical device products to China, they should adopt what risk control measures under what circumstances and report to the drug regulatory authorities to smoothly navigate complex regulatory requirements step by step.

The detailed guidelines for the marketing authorization holders of the overseas and multinational medical device manufacturers exporting medical device products to China, they should proactively conduct the re-evaluation under what circumstances and report to the drug regulatory authorities to smoothly navigate complex regulatory requirements step by step.

The detailed introduction for the Chinese regulatory authorities will carry out the focusing inspections on the marketing authorization holders under what circumstances.

An overview of a Chinese monitoring network for medical device adverse event reporting and monitoring, which covers the detailed regulatory authorities at various administrative levels and their functions, and the complete picture of Chinese monitoring network for medical device adverse event reporting and monitoring to provide a direction of gateway for medical device adverse event reporting and monitoring.

Category: Healthcare Market Research Reports

Contact Details:

Aarkstore Enterprise

Phone: +91 998 729 5242 | contact@aarkstore.com

%d bloggers like this: